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case ofmonarchs, traditional wintering sites
in California and Mexico have been convert-
ed bydevelopment, deforestation, or agricul-
ture. Thus, tens ofmillions ofmonarchs are
restricted to 10 sites in Mexico (5 of them
unprotected by regulations) and only 7
remaining sites in California. The butterflies
are not yet endangered, but a major part of
theirlifecyde is injeopardy.
Outreach in elementary schools has
improved the public's appreciation ofbats.
And BCI is working with mining compa-
nies to convertabandoned mines into roosts
for hibernating bats, creating a human-ani-
mal partnership with mutual benefits. "This
is averyimportant part ofbat ecology," says
French. "We protect [both] the bats and
people with gates at the mine entrances. It
gives ahabitat for bats, and helps give mines
a more positive image."
Pollinators may also benefit from the
move toward more "natural" gardens in pri-
vate homes that demand less pesticide use,
as well as a 1994 Executive Memorandum
issued by President Clinton that recom-
mends the use of regional native plants,
which often evolved with their pollinators
in a mutually beneficial relationship, and
integrated pest management, which features
reduced use ofpesticides on federal and fed-
erally funded properties. And science is
beginning to do its part to protect pollina-
tors, as well. In a paper published in the
February 1998 issue of Conservation Biology,
Nabhan, Bitner, Inouye, and 19 othercoau-
thors propose supporting animal pollinator
services by promoting alternative pollina-
tors, encouraging crop breeders to consider
pollinator attraction in new varieties, pre-
serving pollinator stocks, and researching
ways of increasing pollination and creating
pollinator habitats inagricultural areas.
Melanoma Vaccines
Researchers are making significant progress
in developing innovative treatments for
melanoma, a form ofmalignant skin cancer
that is on the rise in the United States,
according to the American Cancer Society.
Melanoma begins in the melanocytes, the
cells that produce the skin pigment called
melanin. Researchers believe that exposure
to ultraviolet light damages the DNA in
these cells, which results in the development
ofmelanoma.
Scientists have beenworking foryears to
develop vaccines that treat melanoma by
stimulating the immune system to attack
cancer cells. The body does not ordinarily
attack melanoma cells because such cells are
roughly 99% normal, says Philip
Livingston, head of the cancer vaccinology
laboratory at Memorial Sloan-Kettering
Cancer Center in New York City.
Researchers have sought to identify the dif-
ferences that explain why some cells turn
cancerous. "We've spent many years in the
laboratory trying to define and isolate the
genetic elements and the genes that code for
what is different on a cancer cell compared
to a normal cell that the immune system
can recognize," says Steven Rosenberg, chief
ofsurgery at the National Cancer Institute
(NCI).
Livingston refers to these characteristic
elements ofcancer cells, which include pro-
teins and antigens, as "handles." Researchers
developing melanoma vaccines replicate
these handles and combine them with
immune boosters, or substances that the
immune system recognizes and attacks.
Theoretically, linking the handles with sub-
stances known to elicit an immune response
will prompt the body to seekout all handles
and therewith eliminate the cancer cells.
Although the practical application of such
vaccines is years away, scientists are making
significant advances in the area. "This is a
mammoth field," says Paul Chapman, an
associate attending physician and head of
the melanoma section at Memorial Sloan-
Kettering Cancer Center. "There are many
vaccines that are being tested, and all are
equallypromising."
Researchers at Memorial Sloan-
Kettering are working on melanoma vac-
cines that contain one of three replicated
chemicals-GM2, GD2, or GD3-that are
located on melanoma cells and that have
been found to be recognized by the
immune system. The vaccines combine the
chemicals with QS21, an immune booster
from the South American soapbark tree,
and KLH, an antigen produced by the mol-
lusk Megathura crenulata. Early results show
an improvement in survival rates in some
patients.
Rosenberg and colleagues at the NCI
have chosen to work with cancer cell pep-
tides that the immune system can recognize.
They have modified the peptides so they
can better bind to the immune cells-cyto-
toxic T lymphocytes-that attack
melanoma cells. The modified peptides are
then injected into the body. In a recent
study published in the March 1998 issue of
Nature Medicine, Rosenberg and colleagues
reported that, when administered with
interleukin-2, a medication that boosts the
immune system to help slow the growth of
cancer, the vaccine caused an immune sys-
tem response. They also found that 13 of31
patients showed at least partial tumor
shrinkage in the lung or skin, among other
sites.
Another promising vaccine has been
developed by Donald Morton and col-
leagues at the John Wayne Cancer Institute
in Santa Monica, California. Morton col-
lected blood, tissue, and serum samples
from melanoma patients for many years.
Study ofthese samples enabled him to iden-
tify three cancer cell lines that provoke
strong immune system responses. Morton is
working on a vaccine that uses radiated
melanoma cells containing many different
handles combined with bacillus Calmette-
Guerin, a known immune booster. Morton
is currently conducting worldwide clinical
trials on thevaccine.
New Source of Fish Fears
In the Snook Nook bait shop in Jensen
Beach, Florida, snapshots ofanglers holding
up their prize catches attest to the rich
bounty for which the adjacent Indian River
is famous. A few yards from the shop, in a
cramped trailer owned by the Florida
Department of Environmental Protection
(DEP), is another photographic testament
to the Indian River's fish. These close-up
shots show fish with bloody, open sores
reminiscent of those associated with the
toxic dinoflagellate Pfiesteriapiscicida.
The sickened fish in the photos began
appearing early this spring on the hooks of
anglers fishing around the juncture of
Florida's Indian and St. Lucie rivers, a
brackish region known as the St. Lucie
Estuary. At least 33 species of fish were
affected. Although the lesions mimic those
associated with the Pfiesteria outbreaks that
have killed millions offish in Maryland and
North Carolina, the estuary apparently har-
bors a different culprit; nearly all the sick-
ened fish in the estuarywere found alive.
Water samples revealed the presence of
Cryptoperidiniopsis ("crypto"), one of10 rec-
ognized Pfiesteria-like species ofmicroalgae.
Karen Steidinger, a senior research scientist,
andJan Landsberg, aresearch scientist, both
of the DEP's Florida Marine Research
Institute in St. Petersburg, first identified
crypto in 1997 in water samples taken from
St. John's River near Jacksonville. Like
Pfiesteria, crypto is a heterotrophic dinofla-
gellate that feeds on microalgal prey. Crypto
coexists with Pfiesteria in Maryland and
North Carolina, but appears to live apart
from anyrelated species in Florida.
Whether it's causing the ulcers in the St.
Lucie fish, though, is not clear. Of the
2,000 known species of dinoflagellates,
about 65 have been shown to produce tox-
ins. "There's no evidence [crypto] is toxic,"
says JoAnn Burkholder, an associate profes-
sor ofbotany and aquatic ecology at North
Carolina State University in Raleigh, who
in 1991 helped identify Pfiesteria. "We
don't understand much about toxin pro-
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